基本信息
views: 73
![](https://originalfileserver.aminer.cn/sys/aminer/icon/show-trajectory.png)
Bio
Research interest
A particular focus for our laboratory is a family of innate immune receptors known as Nod-like receptors (NLRs). Many of these have the capacity to form intracellular protein complexes called inflammasomes. These biological structures process the pro-inflammatory cytokines IL-1b and IL-18 into their mature forms. Our research has identified substances that activate the inflammasome, and mechanisms by which this inflammation causes disease.
Activation of the inflammasome also triggers an inflammatory form of cell death known as pyroptosis. This programmed form of cell death is a way by which an infected cell can prevent the spread of a micro-organism, but it can also contribute to inflammatory pathology during disease. We are researching the triggers and effectors for this new form of cell death.
This is a particularly exciting time to be working on inflammation because so many new drugs are coming to the clinic. We have the diverse research tools to determine where and why these new drugs can provide benefit.
A particular focus for our laboratory is a family of innate immune receptors known as Nod-like receptors (NLRs). Many of these have the capacity to form intracellular protein complexes called inflammasomes. These biological structures process the pro-inflammatory cytokines IL-1b and IL-18 into their mature forms. Our research has identified substances that activate the inflammasome, and mechanisms by which this inflammation causes disease.
Activation of the inflammasome also triggers an inflammatory form of cell death known as pyroptosis. This programmed form of cell death is a way by which an infected cell can prevent the spread of a micro-organism, but it can also contribute to inflammatory pathology during disease. We are researching the triggers and effectors for this new form of cell death.
This is a particularly exciting time to be working on inflammation because so many new drugs are coming to the clinic. We have the diverse research tools to determine where and why these new drugs can provide benefit.
Research Interests
Papers共 221 篇Author StatisticsCo-AuthorSimilar Experts
By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Rheumatology (Oxford, England)no. 3 (2024): 882-890
Yaoyuan Zhang,Rhiannon Morris, Grant J. Brown,Ayla May D. Lorenzo,Xiangpeng Meng,Nadia J. Kershaw,Pamudika Kiridena,Gaetan Burgio, Simon Gross,Jean Y. Cappello,Qian Shen,Hao Wang,
JOURNAL OF EXPERIMENTAL MEDICINEno. 4 (2024)
Sophia Davidson,Yuri Shibata, Sophie Collard, Hongyu Zheng, Klara Kong, June M Sun,Pawat Laohamonthonkul, Anthony Cerra,Tobias Kratina, CIRCA, AADRY,Margaret W Y Li,
The Journal of experimental medicineno. 6 (2024)
The EMBO Journalno. 5 (2023)
Sophia Davidson,Yuri Shibata, Sophie Collard, Pawat Laohamonthonku, Klara Kong, June Sun, CIRCA, AADRY,Margaret W.Y. Li,Carolyn Russell, Anna van Beek,Edwin P. Kirk,
medRxiv (Cold Spring Harbor Laboratory) (2023)
Nature immunologyno. 4 (2023): 561-562
L. S. Tran, L. Ying,K. D’Costa,G. Wray-McCann, G. Kerr,L. Le,C. C. Allison,J. Ferrand,H. Chaudhry, J. Emery,A. De Paoli, N. Colon,
Nature communicationsno. 1 (2023): 3804-18
Load More
Author Statistics
Co-Author
Co-Institution
D-Core
- 合作者
- 学生
- 导师
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn